You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,663,699


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,663,699 protect, and when does it expire?

Patent 8,663,699 protects ACANYA and is included in one NDA.

This patent has twenty patent family members in fourteen countries.

Summary for Patent: 8,663,699
Title:Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
Inventor(s): Chang; Yunik (Sonoma, CA), Dow; Gordon J. (Santa Rosa, CA)
Assignee: Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:13/869,494
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,663,699
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

United States Patent 8,663,699: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,663,699, hereafter referred to as the '699 patent, is a significant intellectual property asset in the pharmaceutical sector. This patent pertains to specific formulations and methods related to pharmaceuticals, and understanding its scope, claims, and the surrounding patent landscape is crucial for stakeholders in the industry.

Background of the Patent

The '699 patent was granted to a pharmaceutical company for innovations related to topical pharmaceutical formulations. These formulations typically involve the use of active ingredients such as benzoyl peroxide, which are suspended in water and water-miscible organic solvents[2].

Scope of the Patent

Claims Overview

The '699 patent includes a series of claims that define the scope of the invention. These claims are categorized into independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims and provide more specific details.

Key Claim Elements

  • Active Ingredients: The patent specifies the use of benzoyl peroxide as the primary active ingredient.
  • Formulation Composition: The claims detail the composition of the formulation, including the concentration of benzoyl peroxide and the types of solvents used.
  • Method of Preparation: The patent also includes claims related to the method of preparing these formulations.

Claim Examples

For instance, Claim 1 might describe a topical pharmaceutical formulation comprising a specific concentration of benzoyl peroxide suspended in a mixture of water and a water-miscible organic solvent. Subsequent claims might detail variations in the concentration of benzoyl peroxide or the types of solvents used.

Patent Claims Analysis

Claim Dependency

Understanding the dependency between claims is vital. Dependent claims often narrow the scope of the independent claims by adding additional limitations. For example, a dependent claim might specify a particular range of benzoyl peroxide concentration that is narrower than what is described in the independent claim.

Claim Scope and Breadth

The breadth of the claims determines the extent of protection afforded by the patent. Broader claims provide wider protection but are more susceptible to challenges based on prior art. Narrower claims, while more specific, offer less protection but are generally more defensible.

Patent Landscape

Related Patents

The '699 patent is part of a larger family of patents related to pharmaceutical formulations. Understanding the relationships between these patents is crucial for navigating the patent landscape.

  • Continuation-in-Part Patents: Similar to the scenario described in the Cellect case, the '699 patent might be part of a series of continuation-in-part patents, where each subsequent patent builds upon the earlier ones[1].
  • Terminal Disclaimers: In cases where there are multiple patents with overlapping claims, terminal disclaimers might be used to overcome obviousness-type double patenting (ODP) issues.

Competitor Patents

Analyzing competitor patents in the same field can reveal potential areas of conflict or opportunities for differentiation. For instance, other companies may have patents on similar formulations but with different active ingredients or preparation methods.

Search and Analysis Tools

USPTO Resources

The United States Patent and Trademark Office (USPTO) provides several tools for searching and analyzing patents:

  • Patent Public Search: This tool allows for comprehensive searches of prior art and existing patents[4].
  • Global Dossier: This service provides access to file histories of related applications from participating IP offices, helping to identify patent families and related applications[4].

International Patent Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can help in identifying global patent landscape trends and potential conflicts[4].

Economic and Strategic Implications

Patent Term Adjustment (PTA)

The '699 patent, like other patents, may be subject to Patent Term Adjustment (PTA) due to delays during the prosecution process. Understanding how PTA affects the expiration date of the patent is crucial for strategic planning[1].

Market Impact

The '699 patent can significantly impact the market by preventing competitors from using similar formulations. This can lead to market dominance for the patent holder, especially if the formulation is highly effective and in demand.

Legal Considerations

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA. The Cellect case highlights the importance of ODP analysis in such scenarios[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. These disclaimers ensure that the later-expiring patent does not extend beyond the expiration date of the earlier patent[1].

Key Takeaways

  • Scope and Claims: The '699 patent's scope is defined by its claims, which specify the formulation composition, active ingredients, and method of preparation.
  • Patent Landscape: Understanding related patents, competitor patents, and international patent databases is essential for navigating the patent landscape.
  • Legal Considerations: ODP analysis and terminal disclaimers are critical in ensuring the validity and enforceability of the patent.
  • Economic Implications: The patent can significantly impact market dynamics and provide a competitive advantage.

FAQs

What is the primary active ingredient in the formulations described in the '699 patent?

The primary active ingredient is benzoyl peroxide.

How do dependent claims affect the scope of the '699 patent?

Dependent claims narrow the scope of the independent claims by adding additional limitations, making them more specific but less broad.

What is the significance of Patent Term Adjustment (PTA) in the context of the '699 patent?

PTA can extend the term of the patent due to delays during the prosecution process, affecting its expiration date and strategic planning.

How does obviousness-type double patenting (ODP) impact the '699 patent?

ODP prevents securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA.

What tools are available for searching and analyzing patents related to the '699 patent?

Tools include the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the EPO, JPO, and WIPO.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. Topical pharmaceutical formulations containing low concentrations of benzoyl peroxide - PubChem[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Search for patents - USPTO[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,663,699

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch ACANYA benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 050819-001 Oct 23, 2008 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF ACNE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.